Loxoprofen sodium hydrogel patch ( DrugBank: Loxoprofen )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 271 | Ankylosing spondylitis | 1 |
271. Ankylosing spondylitis
Clinical trials : 574 / Drugs : 359 - (DrugBank : 68) / Drug target genes : 41 - Drug target pathways : 146
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03800797 (ClinicalTrials.gov) | May 25, 2015 | 7/1/2019 | Efficacy and Safety of Loxoprofen Hydrogel Patch in Patients With Ankylosing Spondylitis | Efficacy and Safety of Loxoprofen Hydrogel Patch Versus Loxoprofen Tablet in Patients With Ankylosing Spondylitis: a 4-week Randomized, Open-label Study | Ankylosing Spondylitis | Drug: Loxoprofen sodium hydrogel patch;Drug: Loxoprofen sodium tablet | Sun Yat-sen University | NULL | Completed | 18 Years | 65 Years | All | 70 | Phase 4 | China |